phloretin has been researched along with Obesity in 5 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phloretin and its glycoside phlorizin have been reported to prevent obesity induced by high-fat diet (HFD), but the effect of 3-OH phloretin, a catechol metabolite of phloretin, has not been investigated." | 8.31 | 3-OH Phloretin Inhibits High-Fat Diet-Induced Obesity and Obesity-Induced Inflammation by Reducing Macrophage Infiltration into White Adipose Tissue. ( Cao, NT; Choi, H; Jang, J; Kang, HS; Nguyen, NA; Seon, JE; Woo, SM; Yee, SM; Yun, CH, 2023) |
| "The rising prevalence of type 2 diabetes mellitus (T2DM) and accompanying insulin resistance is alarming globally." | 5.91 | Phloretin and phlorizin mitigates inflammatory stress and alleviate adipose and hepatic insulin resistance by abrogating PPARγ S273-Cdk5 interaction in type 2 diabetic mice. ( Chhimwal, J; Kumar, S; Padwad, YS; Patial, V; Purohit, R; Singh, R, 2023) |
| "Phloretin treatment significantly blocks high-fat diet-induced weight gain but did not induce weight loss in obese animals." | 5.46 | Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis. ( Alsanea, S; Gao, M; Liu, D, 2017) |
| "Phloretin and its glycoside phlorizin have been reported to prevent obesity induced by high-fat diet (HFD), but the effect of 3-OH phloretin, a catechol metabolite of phloretin, has not been investigated." | 4.31 | 3-OH Phloretin Inhibits High-Fat Diet-Induced Obesity and Obesity-Induced Inflammation by Reducing Macrophage Infiltration into White Adipose Tissue. ( Cao, NT; Choi, H; Jang, J; Kang, HS; Nguyen, NA; Seon, JE; Woo, SM; Yee, SM; Yun, CH, 2023) |
| "The rising prevalence of type 2 diabetes mellitus (T2DM) and accompanying insulin resistance is alarming globally." | 1.91 | Phloretin and phlorizin mitigates inflammatory stress and alleviate adipose and hepatic insulin resistance by abrogating PPARγ S273-Cdk5 interaction in type 2 diabetic mice. ( Chhimwal, J; Kumar, S; Padwad, YS; Patial, V; Purohit, R; Singh, R, 2023) |
| "Phloretin treatment significantly blocks high-fat diet-induced weight gain but did not induce weight loss in obese animals." | 1.46 | Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis. ( Alsanea, S; Gao, M; Liu, D, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woo, SM | 1 |
| Nguyen, NA | 1 |
| Seon, JE | 1 |
| Jang, J | 1 |
| Yee, SM | 1 |
| Cao, NT | 1 |
| Choi, H | 1 |
| Yun, CH | 1 |
| Kang, HS | 1 |
| Kumar, S | 2 |
| Chhimwal, J | 1 |
| Singh, R | 1 |
| Patial, V | 1 |
| Purohit, R | 1 |
| Padwad, YS | 1 |
| Alsanea, S | 1 |
| Gao, M | 1 |
| Liu, D | 1 |
| Hellman, B | 2 |
| Lernmark, A | 1 |
| Sehlin, J | 2 |
| Täljedal, IB | 2 |
5 other studies available for phloretin and Obesity
| Article | Year |
|---|---|
3-OH Phloretin Inhibits High-Fat Diet-Induced Obesity and Obesity-Induced Inflammation by Reducing Macrophage Infiltration into White Adipose Tissue.
Topics: Adipose Tissue; Adipose Tissue, White; Animals; Diet, High-Fat; Inflammation; Insulin Resistance; Ma | 2023 |
Phloretin and phlorizin mitigates inflammatory stress and alleviate adipose and hepatic insulin resistance by abrogating PPARγ S273-Cdk5 interaction in type 2 diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin Resistance; Mice; Obesi | 2023 |
Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis.
Topics: Adipose Tissue, White; Adiposity; Animals; Antioxidants; Diet, High-Fat; Drug Evaluation, Preclinica | 2017 |
The pancreatic -cell recognition of insulin secretagogues. V. Binding and stimulatory action of phlorizin.
Topics: Animals; Antimycin A; Arginine; Carbon Isotopes; Chloromercuribenzoates; Chlorpromazine; Diabetes Me | 1972 |
Transport of 3-O-methyl-D-glucose into mammalian pancreatic -cells.
Topics: Animals; Biological Transport, Active; Carbon Isotopes; Cell Membrane; Glucosamine; Glucose; Heptose | 1973 |